You are here:Home-ADCs and PROTACs-PROTAC-PIK5-12d
PIK5-12d

Chemical Structure : PIK5-12d

CAS No.:

PIK5-12d (PIKfyve PROTAC)

Catalog No.: PC-21468Not For Human Use, Lab Use Only.

PIK5-12d is a highly potent, selective, first-in-class PIKfyve PROTAC degrader, potently degrades PIKfyve protein with DC50 value of 1.48 nM and Dmax value of 97.7% in prostate cancer VCaP cells.

Packing Price Stock Quantity
1 mg $228 In stock
5 mg $478 In stock
10 mg Get quote
25 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

PIK5-12d is a highly potent, selective, first-in-class PIKfyve PROTAC degrader, potently degrades PIKfyve protein with DC50 value of 1.48 nM and Dmax value of 97.7% in prostate cancer VCaP cells.
PIK5-12d (100 nM) causes fast degradation of PIKfyve protein with a t1/2 value of 1.5 h in VCaP cells, also effectively reduces PIKfyve in other prostate cancer PC3, LNCaP, and 22RV1 cells.
PIK5-12d is a highly specific PIKfyve degrader with only 3 proteins significantly downregulated including PIKfyve, which accounts for the off-target rate at 2 out of 7573 detectable proteins.
PIK5-12d is selective for PIKfyve over other lipid kinases.
PIK5-12d mediated-PIKfyve degradation is VHL and proteasome-dependent.
PIK5-12d induces massive cytoplasmic vacuolization and blocks autophagy in prostate cancer cells.
PIK5-12d inhibits VCaP cell proliferation with an IC50 of 522.3 nM, exerts prolonged suppression of PIKfyve downstream signaling.
PIK5-12d (10 mg/kg) almost completely depleted PIKfyve protein in LTL-331R human prostate cancer patient-derived xenograft (PDX) model, significantly suppressed tumor proliferation in vivo.

Physicochemical Properties

M.Wt 973.21
Formula C52H64N10O7S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N1-((S)-1-((2S,4R)-4-Hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)-N6-(4-(2-((4-(2-((E)-3-methylbenzylidene)hydrazineyl)-6-morpholinopyrimidin-2-yl)oxy)ethyl)phenyl)adipamide

References

1. Chungen Li, et al. J Med Chem. 2023 Sep 14;66(17):12432-12445.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: